Clinical Trial Update: Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event. [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing patient satisfaction after switching to mirabegron for overactive bladder in patients dissatisfied with antimuscarinic therapy or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Myrbetriq (mirabegron)

Snippet

Sponsor: Samsung Medical Center | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED